Fonte Botânica

Isorhamnetin-3-O-robinobioside is a flavonoid glycoside, classified as a secondary plant metabolite. This compound is primarily sourced from various medicinal plants, where it is naturally present as a bioactive constituent. Its mode of action is predominantly based on its antioxidative properties. By scavenging free radicals and inhibiting oxidative stress, it may contribute to the stabilization of cellular environments and reduction of oxidative damage within biological systems. Research into Isorhamnetin-3-O-robinobioside has explored its potential applications in fields such as pharmacology and nutraceuticals. It is being studied for its possible protective roles in diseases related to oxidative stress, including cardiovascular and neurodegenerative disorders. Ongoing investigations aim to elucidate its molecular pathways and therapeutic relevance, supporting the development of novel strategies to harness its biochemical properties.

Theaflavin-3-gallate has anticancer and apoptotic effects in non-small cell lung carcinoma, it acts as prooxidants and induce oxidative stress, with carcinoma cells more sensitive than normal fibroblasts. Theaflavin-3-gallate can play a role in decreased intestinal cholesterol absorption via inhibition of micelle formation.

Quinovic acid 3-O-(6-deoxy-b-D-glucopyranoside) 28-O-b-D-glucopyranosyl ester is a natural triterpenoid glycoside, which is derived from plants belonging to the Rubiaceae family. This compound is primarily extracted from the bark of certain species, such as those from the genus *Uncaria*. With its complex glycoside structure, it acts by modulating various biochemical pathways, including anti-inflammatory and antiviral mechanisms, possibly through the inhibition of viral replication or interference with inflammatory cytokine production. The potential applications of Quinovic acid 3-O-(6-deoxy-b-D-glucopyranoside) 28-O-b-D-glucopyranosyl ester are diverse. It has been subject to research in pharmacology for its prospective uses in treating viral infections and inflammatory conditions. Furthermore, its role in traditional medicine systems as a natural remedy underscores its importance in drug development studies aimed at discovering novel therapeutics derived from natural products.

Tenacigenoside A is a glycoside compound, which is derived from the plant genus Marsdenia, often found in traditional Chinese medicine. It is primarily sourced from the roots and leaves of Marsdenia tenacissima, a plant known for its diverse range of bioactive compounds. The mode of action of Tenacigenoside A involves the modulation of cellular pathways, including apoptosis and cell cycle arrest, suggesting its potential role in influencing various biological processes. Research has indicated that Tenacigenoside A may exhibit antitumor, anti-inflammatory, and immunomodulatory effects. Its ability to induce apoptosis in cancer cells and inhibit cell proliferation makes it a compound of interest for oncological studies. Furthermore, due to its complex interaction with cellular targets, it is being explored for its therapeutic potential against various diseases beyond cancer, such as inflammatory disorders. Consequently, Tenacigenoside A is a subject of ongoing investigation aimed at elucidating its full spectrum of activities and potential clinical applications.

Ziyuglycoside I, isolated from S. officinalis root extract, has anti-wrinkle activity, could be used as an active ingredient for cosmetics.